Oncogenic KRAS activation has been shown to rewire the metabolic program of cancer cells to fuel the energetic and biosynthetic demands of deregulated proliferation, leading to elevated production of intracellular ROS (Guo et al, 2011; Son et al, 2013; Yun et al, 2015). This evidence concerns the gene KRAS and cancer.